InfuSystem implements stock repurchase program
By HME News Staff
Updated 10:16 AM CDT, Wed June 30, 2021
ROCHESTER HILLS, Mich. – The board of directors of InfuSystem Holdings has approved a stock repurchase program allowing the company to purchase up to $20 million in stocks through June 30, 2024. “This authorization will replace the prior authorization which expired on Dec. 31, 2020, and will provide us with an additional capital allocation option to enhance shareholder value,” said Richard Dilorio, CEO. “Additionally, the stock repurchase program emphasizes the confidence that management has in the company’s solid operations, strength of our balance sheet and the outlook for strong growth in 2022 and beyond.” InfuSystem’s top priority for using the capital remains making strategic investments that position the company for sustainable growth, but it also provides the company with the flexibility to be “opportunistic” in repurchasing shares when valuations become attractive, Dilorio says.
Comments